Clínic Barcelona

Researchers propose a new biomarker that may be key in the diagnosis of psychotic outbreaks

Researchers from the Hospital Clínic-IDIBAPS, the Research Institute of the Hospital de Sant Pau – IIB Sant Pan and the CIBERER confirm that the molecule could accurately and non-invasively identify whether the origin of a psychotic outbreak is autoimmune or psychiatric.

Researcher from the Neuromuscular Diseases group at IIB Sant Pau handling the study samples that have allowed the determination of a new biomarker for the diagnosis of psychotic outbreaks.

Keep reading about:

Related news